<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - Millennium Pharmaceuticals</title>
    <link>http://www.newstin.co.uk/uk/MILLENNIUM_PHARMACEUTICALS</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Millennium Pharmaceuticals - News</title>
      <link>http://www.newstin.co.uk/uk/MILLENNIUM_PHARMACEUTICALS</link>
      <description>You are currently using FREE feeds from Newstin. You will get more data and services with Newstin Pro RSS licensed subscription.&lt;br/&gt;Newstin Pro RSS provides aggregated and categorized news content covering 1.25 Million news categories from 160.000 online sources in the format that can be easily integrated into environment or software of your choice. &lt;a href="http://corp.newstin.com/static.a?tpl=corp_rss"&gt;Read more about Newstin Pro RSS&lt;/a&gt; or &lt;a href="http://corp.newstin.com/files/corp/newstin_prorss.pdf"&gt;download the product presentation now&lt;/a&gt;.</description>
      <pubDate>Thu, 26 Nov 2009 13:27:09 GMT</pubDate>
      <guid>http://www.newstin.co.uk/uk/MILLENNIUM_PHARMACEUTICALS</guid>
      <dc:date>2009-11-26T13:27:09Z</dc:date>
    </item>
    <item>
      <title>Biotech's Darwinian Model of Availability</title>
      <link />
      <description />
      <pubDate>Wed, 25 Nov 2009 18:15:33 GMT</pubDate>
      <guid />
      <dc:date>2009-11-25T18:15:33Z</dc:date>
    </item>
    <item>
      <title>Role of Type 1 Interferons in Autoimmune Diseases</title>
      <link />
      <description />
      <pubDate>Wed, 25 Nov 2009 16:43:00 GMT</pubDate>
      <guid />
      <dc:date>2009-11-25T16:43:00Z</dc:date>
    </item>
    <item>
      <title>Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference</title>
      <link />
      <description />
      <pubDate>Tue, 24 Nov 2009 19:48:53 GMT</pubDate>
      <guid />
      <dc:date>2009-11-24T19:48:53Z</dc:date>
    </item>
    <item>
      <title>VerifyNow(R) System Highlighted In POPular Study Comparing Platelet Reactivity Tests</title>
      <link />
      <description />
      <pubDate>Fri, 20 Nov 2009 13:35:23 GMT</pubDate>
      <guid />
      <dc:date>2009-11-20T13:35:23Z</dc:date>
    </item>
    <item>
      <title>Research and Markets: Strategies for Building Early-Stage Pharmaceutical Pipelines Through...</title>
      <link />
      <description />
      <pubDate>Fri, 20 Nov 2009 16:36:07 GMT</pubDate>
      <guid />
      <dc:date>2009-11-20T16:36:07Z</dc:date>
    </item>
    <item>
      <title>Millennium Initiates First Clinical Trial With The First Oral Proteasome Inhibitor</title>
      <link />
      <description />
      <pubDate>Thu, 19 Nov 2009 17:25:36 GMT</pubDate>
      <guid />
      <dc:date>2009-11-19T17:25:36Z</dc:date>
    </item>
    <item>
      <title>New Weapons in Medicine - BusinessWeek</title>
      <link />
      <description />
      <pubDate>Mon, 16 Nov 2009 02:52:23 GMT</pubDate>
      <guid />
      <dc:date>2009-11-16T02:52:23Z</dc:date>
    </item>
    <item>
      <title>Fate Seals $30 M Series B, Gets Corporate Venture On Board</title>
      <link />
      <description />
      <pubDate>Mon, 16 Nov 2009 12:00:00 GMT</pubDate>
      <guid />
      <dc:date>2009-11-16T12:00:00Z</dc:date>
    </item>
    <item>
      <title>Redfin Raises a $10 Million Venture Capital Round Led by Greylock Partners (PR Newswire)</title>
      <link />
      <description />
      <pubDate>Thu, 12 Nov 2009 19:49:29 GMT</pubDate>
      <guid />
      <dc:date>2009-11-12T19:49:29Z</dc:date>
    </item>
  </channel>
</rss>

